// App-Quantinova.ai

P4-01-04 : Circulating tumor cells (CTC) are associated with defects in innate and adaptive immunity in inflammatory breast cancer (IBC) patients

Researchers

Presenter

  • Mego M

Principal Investigators

  • Gao H

  • Cohen EN

  • Hortobagyi GN

  • Cristofanilli M

  • Reuben JMAnfossi SGiordano A

  • Tin S

  • Fouad TM

  • Woodward WA

  • Alvarez RH

  • Valero V

  • Ueno NT

Medical Centers

  • Thomas Jefferson University Kimmel Cancer Center, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved